PSNL 241220 7.50P (PSNL241220P7500) Stock Options, News & Quotes

0.95
0.000.00%

15min DelayClose Dec 20 16:00 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

103810665

Dec 28 04:38

Latest portfolio.

Thanks moomoo for its screener features. i really appreciate it.

Share Your Profit/Loss

103810665

Dec 28 04:35

Still consider as beginner's luck

Since more than 1 month ago opening account with moomoo. The best thing about moomoo is in its screener features, can be customized its parameter. Therefore I can easily scan & identified potential stocks to buy. So far 2 counter sell cutloss, but now 3 counters still holding & profiting.

Share Your Profit/Loss

Jaguar8

Dec 19 17:46

🟢 Watchlist FRIDAY December 20,2024. N F A !

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...

Jaguar8

Dec 19 08:01

NEWS

$Personalis (PSNL.US)$
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
Thursday, 19th December at 9:00 am
Personalis, Inc. (NASDAQ: PSNL) announced today agreements with long time collaborators Merck and Moderna that accelerate the advancement of the company's business strategy. The company has received an investment from Merck, known as MSD outside the United States and Canada, and separately has signed a multi-year extension with Mode...

Jaguar8

Dec 16 07:04

NEWS

$Personalis (PSNL.US)$
Personalis and Tempus Expand Collaboration to Biopharma
Monday, 16th December at 8:00 am
Expanded collaboration to yield greater biopharma access to Personalis' MRD solution
Personalis, Inc. (NASDAQ: PSNL) and Tempus AI, Inc. (NASDAQ: TEM) announced today that the companies have expanded their commercial relationship. The companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Soc...